The Epeldegui lab, which is in the UCLA AIDS Institute, David Geffen School of Medicine at UCLA, seeks a Post-Doctoral Scholar for a multiple year research appointment. The NIH grant funded position will work under the director of Marta Epeldegui, Ph.D., M.S., Associate Professorin-Residence.
Dr. Epeldegui’s research focuses in the role of immune dysfunction and cancer, especially AIDSassociated B cell non-Hodgkin lymphoma (ARL). ARL remains a significant problem even in the era of combination anti-retroviral treatment (cART). Her research work and others have shown that B cell activation and microbial translocation precede the development of ARL, with elevated levels of biomarkers associated with B cell activation and microbial translocation seen prior to ARL diagnosis. Moreover, biomarkers of inflammation, B cell activation and microbial translocation are also associated with cancer prognosis. Her laboratory studies how inflammation, microbial translocation, viral infections and other events may lead to lymphomagenesis and pathogenesis of ARL.
Applicants must possess a Ph.D., M.D. or M.D./Ph.D. degree to apply. Qualified applicants can include graduate students in their last year of work toward a Ph.D. degree, who have successfully defended their thesis, or applicants who are in the first year of a postdoctoral appointment. Candidates are expected to have a strong background in immunology, molecular and cell biology and have experience with flow cytometry. The ideal candidate should be highly motivated and have publications in peer-reviewed journals.
Interested candidates can apply online through the UC Recruit system.
For more information about the position or general inquiries, please contact Dr. Marta Epeldegui at [email protected]
The lab of Dr. Sandra Orsulic at the UCLA David Geffen School of Medicine seeks a Post Doctoral Scholar for a multiple year research appointment. The grant funded position will work under Dr. Orsulic’s direction in the Department of Obstetrics and Gynecology, Division of Gynecologic Oncology.
Dr. Orsulic’s research focuses on the development of mouse models in which ovarian cancer can be induced and studied during its early stages of growth and metastatic progression. Her laboratory has generated multiple syngeneic mouse ovarian cancer cell lines with defined genetic alterations that recapitulate the development and pathophysiological manifestations of human ovarian cancer as well as the complexity of cancer-stroma interactions. These models are used to determine the functional contributions of individual molecular pathways to cell transformation, immune response to cancer progression, recruitment of cancer-associated fibroblasts, and development of therapy resistance.
Applicants must possess a Ph.D., M.D. or M.D./Ph.D. degree. Qualified applicants can include graduate students in their last year of obtaining a Ph.D. who have successfully defended their thesis or applicants who are in the first year of a postdoctoral appointment. Candidates are expected to have a strong background in molecular and cell biology and have experience with -omics analyses and small animal surgical procedures. The ideal candidate should be highly motivated and have publications in peer-reviewed journals.
Salary is commensurate with experience and skill level.
Applicants must provide the following documents to apply:
Following interviews, the final candidate may be asked to provide references. Interested candidates can apply through the UC Recruit system.
Information on the Orsulic Laboratory >
The G.O. Discovery Laboratory at the University of California, Los Angeles (UCLA) is seeking a Postdoctoral Scholar. The laboratory is affiliated with the UCLA Eli and Edythe Broad Cell Research Center, Jonsson Comprehensive Cancer Center, and the Molecular Biology Institute. This appointment will be under the supervision of Professor Sanaz Memarzadeh, M.D., Ph.D., in the Department of Obstetrics and Gynecology at the UCLA David Geffen School of Medicine.
Applications are being sought from recent Ph.D., M.D., or M.D./Ph.D. graduates with a strong background in molecular and cell biology. Candidates are expected to have experience with microscopy, immunohistochemistry, FACS analysis, virology, and immunology. Experience with small animal surgical procedures are strongly preferred. The ideal candidate should be highly motivated and have publications in peer-reviewed journals with at least two being the first author.
The candidate will be part of a scholarly team performing research aimed at developing more effective treatment strategies for therapy of ovarian cancers that can be taken from the laboratory and applied to clinical practice. The candidate will participate in funded translational research programs to study the mechanisms of therapy resistance in ovarian cancers. Focus areas of study will include but are not limited to DNA damage response, cancer initiating tumor cell subpopulations, and the role of immune cells in regulating response to therapy.
Salary will be determined based on qualifications and experience.
Applications will require the following documents:
Interested candidates can apply through the UC Recruit system.
Information regarding the G.O. Discovery Laboratory >
The G.O. Discovery Laboratory at the University of California, Los Angeles (UCLA) is seeking a Postdoctoral Scholar. The laboratory is affiliated with the UCLA Eli and Edythe Broad Cell Research Center, Jonsson Comprehensive Cancer Center, and the Molecular Biology Institute. This appointment will be under the supervision of Professor Sanaz Memarzadeh, M.D., Ph.D., in the Department of Obstetrics and Gynecology at the UCLA David Geffen School of Medicine.
Applications are being sought from recent Ph.D., M.D., or M.D./Ph.D. graduates with a strong background in molecular and cell biology. Candidates are expected to have experience with microscopy, immunohistochemistry, FACS analysis, virology, and immunology. Experience with small animal surgical procedures are strongly preferred. The ideal candidate should be highly motivated and have publications in peer-reviewed journals with at least two being the first author.
The candidate will be joining a scholarly research team focused on pathways that can initiate uterine epithelial cancers and sarcomas, and therapies that can more effectively target these tumors. The goal is to develop strategies that can target these cancers that can be translated from the laboratory to the clinic. The candidate will participate in funded translational research programs to study stromal and epithelial interactions in gynecologic cancers, the role of stem progenitor cells, and approaches to model the disease in vivo.
Salary will be determined based on qualifications and experience.
APPLICATION REQUIREMENTS
Reference requirements
Interested candidates can apply through the UC Recruit system >
Information regarding the G.O. Discovery Laboratory >
The University of California is an Equal Opportunity/Affirmative Action Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, disability, age or protected veteran status. For the complete University of California nondiscrimination and affirmative action policy, see: UC Nondiscrimination & Affirmative Action Policy.
As a condition of employment, you will be required to comply with the University of California SARS-CoV-2 (COVID-19) Vaccination Program Policy. All Covered Individuals under the policy must provide proof of Full Vaccination or, if applicable, submit a request for Exception (based on Medical Exemption, Disability, and/or Religious Objection) or Deferral (based on pregnancy) no later than the applicable deadline. New University of California employees must (a) provide proof of receiving at least one dose of a COVID-19 Vaccine no later than 14 calendar days after their first date of employment and provide proof of Full Vaccination no later than eight weeks after their first date of employment; or (b) if applicable, submit a request for Exception or Deferral no later than 14 calendar days after their first date of employment. (Capitalized terms in this paragraph are defined in the policy.) Federal, state, or local public health directives may impose additional requirements.
